期刊
CLINICAL LUNG CANCER
卷 23, 期 2, 页码 E116-E117出版社
CIG MEDIA GROUP, LP
DOI: 10.1016/j.cllc.2021.12.003
关键词
Immune checkpoint inhibitors; Immune-related pneumonitis; Interstitial lung disease; Lipid-laden macrophage; Respiratory failure
类别
Diagnosing newly emerged abnormal lung shadows during treatment with immune checkpoint inhibitors can be challenging. Clinicians should be aware of this rare but severe phenomenon in patients undergoing immune checkpoint inhibitor therapy.
It is often challenging to diagnose newly emerged abnormal lung shadows during treatment with immune checkpoint inhibitors. We report an autopsy case of a patient who developed lipoid pneumonia after a single dose of pembrolizumab. Clinicians will bear in mind this rare but severe phenomenon in patients undergoing immune checkpoint inhibitor therapy. (C) 2021 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据